These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20215452)

  • 1. Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis.
    Sobngwi E; Enoru S; Ashuntantang G; Azabji-Kenfack M; Dehayem M; Onana A; Biwole D; Kaze F; Gautier JF; Mbanya JC
    Diabetes Care; 2010 Jul; 33(7):1409-12. PubMed ID: 20215452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End-Stage Renal Disease: A Randomized Crossover Study.
    Singhsakul A; Supasyndh O; Satirapoj B
    J Diabetes Res; 2019; 2019():6923543. PubMed ID: 31828166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Software-guided insulin dosing improves intrapartum glycemic management in women with diabetes mellitus.
    Dinglas C; Muscat J; Adams T; Peragallo-Dittko V; Vintzileos A; Heo HJ
    Am J Obstet Gynecol; 2018 Aug; 219(2):191.e1-191.e6. PubMed ID: 29750952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the hemodialysis-induced changes in plasma glucose and insulin concentrations in diabetic patients: comparison between the hemodialysis and non-hemodialysis days.
    Abe M; Kaizu K; Matsumoto K
    Ther Apher Dial; 2007 Aug; 11(4):288-95. PubMed ID: 17661835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic profile and effectiveness and safety of insulin therapy in septic patients: is the blood glucose level sufficient?
    Szrama J; Smuszkiewicz P; Trojanowska I
    Pol Arch Med Wewn; 2009 Oct; 119(10):621-7. PubMed ID: 19847137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of basal insulin analogues on glucose variability in patients with type 2 diabetes undergoing renal replacement therapy for end-stage renal disease.
    Savu O; Elian V; Steriade O; Teodoru I; Mihut S; Tacu C; Covic A; Serafinceanu C
    Int Urol Nephrol; 2016 Feb; 48(2):265-70. PubMed ID: 26725077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis and effect of corrective measures to prevent hypoglycemia.
    Katla V; Khyalappa R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hemodialysis on plasma glucose profile and plasma level of liraglutide in patients with type 2 diabetes mellitus and end-stage renal disease: a pilot study.
    Osonoi T; Saito M; Tamasawa A; Ishida H; Tsujino D; Nishimura R; Utsunomiya K
    PLoS One; 2014; 9(12):e113468. PubMed ID: 25526642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
    Ahmed AB; Mallias J; Home PD
    Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
    Klein O; Lynge J; Endahl L; Damholt B; Nosek L; Heise T
    Diabetes Obes Metab; 2007 May; 9(3):290-9. PubMed ID: 17391154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state.
    Matthews DR; Boland O
    Metabolism; 1997 Dec; 46(12 Suppl 1):5-9. PubMed ID: 9439551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction.
    Cheung NW; Wong VW; McLean M
    Diabetes Care; 2006 Apr; 29(4):765-70. PubMed ID: 16567812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intradialytic hypotension: is midodrine beneficial in symptomatic hemodialysis patients?
    Cruz DN; Mahnensmith RL; Perazella MA
    Am J Kidney Dis; 1997 Dec; 30(6):772-9. PubMed ID: 9398120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.
    Rassam AG; Zeise TM; Burge MR; Schade DS
    Diabetes Care; 1999 Jan; 22(1):133-6. PubMed ID: 10333914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.
    Kipnes M; Dandona P; Tripathy D; Still JG; Kosutic G
    Diabetes Care; 2003 Feb; 26(2):421-6. PubMed ID: 12547873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.